Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.17
Price to sales ratio
1.56

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3551
CHRS
Coherus Oncology, Inc. - Common Stock
1.47 USD-4.55%-13.02%+2.80%-8.70%226.75 M USD
3552
NAUT
Nautilus Biotechnology, Inc. - Common Stock
1.78 USD-5.82%+4.09%-22.27%+131.17%226.20 M USD
3575
ARTV
Artiva Biotherapeutics, Inc. - Common Stock
8.93 USD-7.37%-5.40%+4.20%+114.66%220.72 M USD
3577
KROS
Keros Therapeutics, Inc. - common stock
11.10 USD-5.93%+0.36%+7.25%-26.49%219.69 M USD

Frequently asked questions about Precision BioSciences, Inc. - Common Stock

What is the Precision BioSciences, Inc. - Common Stock stock price today?

The current price of Precision BioSciences, Inc. - Common Stock (DTIL) is 8.59. Over the past 24 hours, the stock has changed by -1.94%. Follow the DTIL chart for real-time price dynamics.

What is the stock ticker of Precision BioSciences, Inc. - Common Stock?

Precision BioSciences, Inc. - Common Stock trades under the ticker DTIL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Precision BioSciences, Inc. - Common Stock stock going up?

DTIL has changed by +4.76% over the last week, +39.00% over the last month, and +86.74% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Precision BioSciences, Inc. - Common Stock net income for the last quarter?

Precision BioSciences, Inc. - Common Stock reported net income of -18.44 M for the last quarter. The previous quarter showed 20.13 M, which means net income changed by -191.60%.

How many employees does Precision BioSciences, Inc. - Common Stock have?

As of the latest available data, Precision BioSciences, Inc. - Common Stock has 66 employees. Workforce size can provide additional context about the company's scale and operations.

What is Precision BioSciences, Inc. - Common Stock EBITDA?

Precision BioSciences, Inc. - Common Stock EBITDA is -8.96 M, and its EBITDA margin is -82.65%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Precision BioSciences, Inc. - Common Stock stock?

You can buy Precision BioSciences, Inc. - Common Stock (DTIL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Precision BioSciences, Inc. - Common Stock stock?

Investing in Precision BioSciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DTIL chart and related analysis on metatrader.com as part of your research.

Precision BioSciences, Inc. - Common Stock

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

News